Connect Biopharma Holdings Limited

CNTB
$2.66 (+ $0.44 + 19.82%)
Last updated: 2026-07-10 06:21 UTC
CNTB Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS2075231017
CUSIP207523101
Market Price2.66
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.89
Market Cap$138.9M
Book Value0.99
Price to Book2.503
Beta-0.18
52w High3.28
52w Low0.51
Next Earnings DateN/A

Connect Biopharma Holdings Limited trades under ticker CNTB on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US2075231017, CUSIP 207523101.

About the Company
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.
Price History